Chemomab Therapeutics, Scipher Medicine to Merge in All-Stock Deal
() -- Chemomab Therapeutics (CMMB) and Scipher Medicine have entered into an all-stock merger agreement, the companies said Wednesday. Under the terms of the merger, Chemomab equity holders are expected to own around 32% of the combined company, and Scipher equity holders are expected to own around 68%, the companies s